Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity (Q81339776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Yao-Chi Chuang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Catherine A Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Shachi Tyagi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Naoki Yoshimura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Pradeep Tyagi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michael B Chancellor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

27 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1353-1357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

7 January 2020

cites work

1 reference

12 December 2020

Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis

1 reference

12 December 2020

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

1 reference

12 December 2020

Muscarinic receptor antagonists for overactive bladder

1 reference

12 December 2020

Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

1 reference

12 December 2020

A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial

1 reference

12 December 2020

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

12 December 2020

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

1 reference

12 December 2020

Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.

1 reference

12 December 2020

Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways

1 reference

12 December 2020

The urothelium in overactive bladder: passive bystander or active participant?

1 reference

12 December 2020

Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro

1 reference

12 December 2020

Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence

1 reference

12 December 2020

Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?

1 reference

12 December 2020

10.1007/S00192-008-0650-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18504514%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference